• Je něco špatně v tomto záznamu ?

SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review

AG. Willison, M. Pawlitzki, MP. Lunn, HJ. Willison, HP. Hartung, SG. Meuth

. 2024 ; 81 (2) : 179-186. [pub] 20240201

Jazyk angličtina Země Spojené státy americké

Typ dokumentu přehledy, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24007284

IMPORTANCE: The temporal association between the occurrence of neurological diseases, many autoimmune diseases, and vaccination against SARS-CoV-2 has been topically interesting and remains hotly debated both in the medical literature and the clinic. Given the very low incidences of these events both naturally occurring and in relation to vaccination, it is challenging to determine with certainty whether there is any causative association and most certainly what the pathophysiology of that causation could be. OBSERVATIONS: Data from international cohorts including millions of vaccinated individuals suggest that there is a probable association between the adenovirus-vectored vaccines and Guillain-Barré syndrome (GBS). Further associations between other SARS-CoV-2 vaccines and GBS or Bell palsy have not been clearly demonstrated in large cohort studies, but the possible rare occurrence of Bell palsy following messenger RNA vaccination is a topic of interest. It is also yet to be clearly demonstrated that any other neurological diseases, such as central nervous system demyelinating disease or myasthenia gravis, have any causative association with vaccination against SARS-CoV-2 using any vaccine type, although it is possible that vaccination may rarely trigger a relapse or worsen symptoms or first presentation in already-diagnosed or susceptible individuals. CONCLUSIONS AND RELEVANCE: The associated risk between SARS-CoV-2 vaccination and GBS, and possibly Bell palsy, is slight, and this should not change the recommendation for individuals to be vaccinated. The same advice should be given to those with preexisting neurological autoimmune disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24007284
003      
CZ-PrNML
005      
20240423155843.0
007      
ta
008      
240412s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1001/jamaneurol.2023.5208 $2 doi
035    __
$a (PubMed)38227318
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Willison, Alice Grizzel $u Department of Neurology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
245    10
$a SARS-CoV-2 Vaccination and Neuroimmunological Disease: A Review / $c AG. Willison, M. Pawlitzki, MP. Lunn, HJ. Willison, HP. Hartung, SG. Meuth
520    9_
$a IMPORTANCE: The temporal association between the occurrence of neurological diseases, many autoimmune diseases, and vaccination against SARS-CoV-2 has been topically interesting and remains hotly debated both in the medical literature and the clinic. Given the very low incidences of these events both naturally occurring and in relation to vaccination, it is challenging to determine with certainty whether there is any causative association and most certainly what the pathophysiology of that causation could be. OBSERVATIONS: Data from international cohorts including millions of vaccinated individuals suggest that there is a probable association between the adenovirus-vectored vaccines and Guillain-Barré syndrome (GBS). Further associations between other SARS-CoV-2 vaccines and GBS or Bell palsy have not been clearly demonstrated in large cohort studies, but the possible rare occurrence of Bell palsy following messenger RNA vaccination is a topic of interest. It is also yet to be clearly demonstrated that any other neurological diseases, such as central nervous system demyelinating disease or myasthenia gravis, have any causative association with vaccination against SARS-CoV-2 using any vaccine type, although it is possible that vaccination may rarely trigger a relapse or worsen symptoms or first presentation in already-diagnosed or susceptible individuals. CONCLUSIONS AND RELEVANCE: The associated risk between SARS-CoV-2 vaccination and GBS, and possibly Bell palsy, is slight, and this should not change the recommendation for individuals to be vaccinated. The same advice should be given to those with preexisting neurological autoimmune disease.
650    _2
$a lidé $7 D006801
650    _2
$a vakcíny proti COVID-19 $x škodlivé účinky $7 D000086663
650    _2
$a SARS-CoV-2 $7 D000086402
650    12
$a Bellova paréza $7 D020330
650    12
$a COVID-19 $x prevence a kontrola $7 D000086382
650    _2
$a lokální recidiva nádoru $7 D009364
650    _2
$a vakcinace $x škodlivé účinky $7 D014611
650    12
$a Guillainův-Barrého syndrom $x etiologie $7 D020275
650    12
$a myasthenia gravis $7 D009157
655    _2
$a přehledy $7 D016454
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pawlitzki, Marc $u Department of Neurology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
700    1_
$a Lunn, Michael Peter $u Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom $u Department of Neuromuscular Disease, Institute of Neurology, University College London, London, United Kingdom
700    1_
$a Willison, Hugh John $u College of Medicine, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom
700    1_
$a Hartung, Hans-Peter $u Department of Neurology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany $u Department of Neurology, Medical University of Vienna, Vienna, Austria $u Brain and Mind Center, University of Sydney, Sydney, Australia $u Department of Neurology, Palacky University, Olomouc, Czech Republic
700    1_
$a Meuth, Sven Günther $u Department of Neurology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany
773    0_
$w MED00180402 $t JAMA neurology $x 2168-6157 $g Roč. 81, č. 2 (2024), s. 179-186
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38227318 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155840 $b ABA008
999    __
$a ok $b bmc $g 2081333 $s 1217051
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 81 $c 2 $d 179-186 $e 20240201 $i 2168-6157 $m JAMA neurology $n JAMA Neurol $x MED00180402
LZP    __
$a Pubmed-20240412
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace